Table 1 Details of medically compromised patients
No. | Age | Gender | Position of implant placement | Diameter of implant | Length of implant | Implant prognosis | Past medical history |
|---|---|---|---|---|---|---|---|
1 | 68 | F | #46i | 4.0 | 8.5 | Success | HTN, osteoporosis, DM |
#47i | 4.0 | 8.5 | Success | ||||
2 | 63 | F | #44i | 4.0 | 10 | Success | Lymphoma |
#45i | 4.0 | 7 | Satisfactory survival | ||||
#46i | 4.0 | 7 | Success | ||||
3 | 73 | M | #44i | 5.0 | 10 | Success | HTN, DM |
4 | 68 | M | #46i | 4.5 | 10 | Success | HTN, DM |
#47i | 4.5 | 8.5 | Success | ||||
#35i | 4.0 | 10 | Satisfactory survival | ||||
#36i | 4.0 | 8.5 | Success | ||||
#37i | 4.0 | 7 | Success | ||||
5 | 69 | F | #37i | 4.5 | 8.5 | Success | HTN, DM, osteoporosis |
#36i | 5.0 | 10 | Success | ||||
6 | 72 | F | #17i | 4.0 | 7 | Success | HTN |
#16i | 4.0 | 8.5 | Success | ||||
#26i | 4.0 | 7 | Success | ||||
7 | 72 | M | #36i | 4.5 | 8.5 | Success | HTN |
#37i | 4.5 | 8.5 | Satisfactory survival | ||||
8 | 77 | M | #45i | 4.5 | 10 | Success | HTN, DM, bleeding tendency |
9 | 86 | F | #37i | 4.0 | 10 | Success | HTN, bleeding tendency |
10 | 74 | F | #47i | 4.5 | 10 | Success | HTN |
11 | 53 | M | #47i | 4.5 | 8.5 | Success | HTN, bleeding tendency |
#14i | 4.0 | 8.5 | Success | ||||
#24i | 4.0 | 8.5 | Success | ||||
#25i | 4.0 | 7 | Success | ||||
#26i | 4.0 | 7 | Success | ||||
12 | 75 | F | #36i | 4.0 | 8.5 | Success | Osteoporosis, bisphosphonate usage |
#37i | 4.0 | 8.5 | Success | ||||
#25i | 4.5 | 8.5 | Success | ||||
13 | 71 | F | #46i | 4.5 | 8.5 | Success | HCV |
14 | 31 | M | #46i | 4.0 | 8.5 | Success | Mental disability |
| Â | Â | Â | #47i | 4.0 | 8.5 | Success | Â |
15 | 70 | F | #16i | 4.5 | 8.5 | Success | HTN, osteoporosis |
16 | 76 | M | #47i | 4.5 | 7 | Success | SCC |
17 | 80 | F | #45i | 4.0 | 8.5 | Satisfactory survival | HTN, osteoporosis |
| Â | Â | Â | #46i | 5.0 | 8.5 | Success | Â |
18 | 58 | F | #37i | 4.0 | 8.5 | Success | HTN, bleeding tendency |
19 | 78 | F | #17i | 5.0 | 7.0 | Failure | HTN, osteoporosis, hypothyroidism |
| Â | Â | Â | #47i | 4.5 | 8.5 | Success | Â |
| Â | Â | Â | #46i | 5.0 | 8.5 | Success | Â |
20 | 39 | M | #36i | 4.5 | 7 | Success | Tongue cancer |
21 | 62 | F | #46i | 4.5 | 8.5 | Success | Bullous pemphigoid |
22 | 69 | M | #26i | 5.0 | 8.5 | Success | HTN, osteoporosis, angina pectoris |
23 | 76 | F | #46ii | 5.0 | 10 | Satisfactory survival | DM, osteoporosis |
24 | 75 | F | #47i | 4.5 | 7 | Success | HTN, DM |
| Â | Â | Â | #36i | 4.0 | 8.5 | Success | Â |
25 | 69 | F | #16i | 4.0 | 8.5 | Success | HTN, osteoporosis |
| Â | Â | Â | #17i | 4.0 | 8.5 | Success | Â |
26 | 46 | M | #16i | 4.0 | 10 | Success | DM |
27 | 82 | F | #47i | 4.5 | 8.5 | Success | HTN, lung cancer, thyroid surgery |
28 | 57 | F | #16i | 4 | 8.5 | Compromised survival | Osteoporosis |
| Â | Â | Â | #17i | 4 | 8.5 | Success | Â |
29 | 65 | M | #36i | M | 8.5 | Success | HTN, hyperlipidemia, gout |